These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3556281)

  • 21. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance.
    Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Pettiti M; Natali A; Mari A; DeFronzo RA
    Diabetologia; 2003 Sep; 46(9):1211-9. PubMed ID: 12879253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of insulin resistance in normoglycemic young adults.
    Preethi BL; Jaisri G; Kumar KM; Sharma R
    Fiziol Cheloveka; 2011; 37(1):118-25. PubMed ID: 21466052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children.
    Carel JC; Boitard C; Bougnères PF
    J Clin Invest; 1993 Jul; 92(1):509-13. PubMed ID: 8326015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.
    Teuscher AU; Kendall DM; Smets YF; Leone JP; Sutherland DE; Robertson RP
    Diabetes; 1998 Mar; 47(3):324-30. PubMed ID: 9519735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet cell antibodies in individuals at increased risk for IDDM.
    Schulz B; Witt S; Hildmann W; Ratzmann KP; Strese J; Keilacker H
    Exp Clin Endocrinol; 1984 Apr; 83(2):192-8. PubMed ID: 6373322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
    Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA
    J Clin Endocrinol Metab; 2005 Jan; 90(1):493-500. PubMed ID: 15483086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.
    Ahrén B; Pacini G
    Eur J Endocrinol; 2004 Feb; 150(2):97-104. PubMed ID: 14763905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.
    Teuscher AU; Seaquist ER; Robertson RP
    Diabetes; 1994 Apr; 43(4):593-8. PubMed ID: 8138066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of short-term experimental insulin resistance and family history of diabetes on pancreatic beta-cell function in nondiabetic individuals.
    Rasouli N; Hale T; Kahn SE; Spencer HJ; Elbein SC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5825-33. PubMed ID: 16091496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans.
    Fritsche A; Madaus A; Stefan N; Tschritter O; Maerker E; Teigeler A; Häring H; Stumvoll M
    Diabetes; 2002 Feb; 51 Suppl 1():S234-9. PubMed ID: 11815485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.
    Buchanan TA; Xiang AH; Peters RK; Kjos SL; Berkowitz K; Marroquin A; Goico J; Ochoa C; Azen SP
    Diabetes; 2000 May; 49(5):782-8. PubMed ID: 10905487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.
    Lalić NM; Marić J; Svetel M; Jotić A; Stefanova E; Lalić K; Dragasević N; Milicić T; Lukić L; Kostić VS
    Arch Neurol; 2008 Apr; 65(4):476-80. PubMed ID: 18413469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times.
    Breda E; Toffolo G; Polonsky KS; Cobelli C
    Diabetes; 2002 Feb; 51 Suppl 1():S227-33. PubMed ID: 11815484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.